{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:54:51Z","timestamp":1787972091450,"version":"build-2784847793"},"reference-count":50,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,24]],"date-time":"2006-01-24T00:00:00Z","timestamp":1138060800000},"content-version":"vor","delay-in-days":1333,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2002,6]]},"abstract":"<jats:p><jats:bold>A<jats:sc>bstract<\/jats:sc>: <\/jats:bold> 3,4\u2010Methylenedioxymethamphetamine (MDMA) has been reported to cause hyponatraemia, which appears to result from inappropriate secretion of the antidiuretic hormone arginine vasopressin (AVP). After administration of a low dose of (<jats:italic>R,S<\/jats:italic>)\u2010MDMA (40 mg) to eight healthy drug\u2010free male volunteers, concentrations of AVP in plasma increased significantly at 1, 2, and 4 hours. Although no relation between plasma MDMA and AVP was found on an examination of the entire data set over the 24\u2010hour study period, a statistically significant negative correlation was observed at 1 hour. As this occurred at a time when both AVP and MDMA concentrations were rising, it was postulated that a metabolite, or metabolites, could primarily be responsible for the increase in AVP. To test this hypothesis we examined the effect of MDMA and five of its metabolites, in the dose range 0.1\u20101,000 nM, on AVP release from the isolated rat hypothalamus. All compounds tested were found to increase AVP release (using 10 nM and 1,000 nM concentrations), with 4\u2010hydroxy\u20103\u2010methoxymethamphetamine (HMMA), the major metabolite of MDMA, being the most potent, and 3,4\u2010dihydroxymethamphetamine (DHMA) the least potent. Each compound (1,000 nM), with the exception of DHMA, also enhanced the response to 40\u2010mM potassium stimulation. Our findings confirm that metabolites of MDMA, in addition to the parent drug, contribute to AVP secretion <jats:italic>in vitro<\/jats:italic>. Further work will demonstrate whether this is also true <jats:italic>in vivo<\/jats:italic>.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2002.tb04181.x","type":"journal-article","created":{"date-parts":[[2010,7,21]],"date-time":"2010-07-21T01:02:54Z","timestamp":1279674174000},"page":"399-409","source":"Crossref","is-referenced-by-count":46,"title":["Action of MDMA (Ecstasy) and Its Metabolites on Arginine Vasopressin Release"],"prefix":"10.1111","volume":"965","author":[{"given":"J. K.","family":"FALLON","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"SHAH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. T.","family":"KICMAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. J.","family":"HUTT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"HENRY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. A.","family":"COWAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"FORSLING","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,1,24]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.258.6.780"},{"key":"e_1_2_4_3_2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/014107689108400622","article-title":"Ecstasy, 3\u20104 methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia","volume":"84","author":"Chadwick I.S.","year":"1991","journal-title":"J. R. Soc. Med."},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)91469-O"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90834-P"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.307.6916.1399"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.308.6925.414"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)90196-8"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.312.7042.1359b"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1997.tb140044.x"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1021\/tx00009a002"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/20.6.432"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/elps.1150180628"},{"key":"e_1_2_4_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb05199.x"},{"key":"e_1_2_4_15_2","first-page":"1203","article-title":"3,4\u2010Dihydroxymethamphetamine (HHMA)","volume":"14","author":"Segura M.","year":"2001","journal-title":"A major in vivo 3,4-methylenedioxymethamphetamine (MDMA) metabolite in humans. Chem. Res. Toxicol."},{"key":"e_1_2_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(94)90386-7"},{"key":"e_1_2_4_17_2","first-page":"1059","article-title":"Oxidation of methamphetamine and methylenedioxymethamphetamine by CYP2D6","volume":"25","author":"Lin L.Y.","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"e_1_2_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(97)00014-2"},{"key":"e_1_2_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(00)00284-7"},{"key":"e_1_2_4_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2000.00121.x"},{"key":"e_1_2_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0040-4020(01)98311-5"},{"key":"e_1_2_4_22_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00250a012"},{"key":"e_1_2_4_23_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00183a006"},{"key":"e_1_2_4_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9888(199711)32:11<1236::AID-JMS584>3.0.CO;2-K"},{"key":"e_1_2_4_25_2","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/clinchem\/45.7.1058","article-title":"Stereospecific analysis and enantiomeric disposition of 3,4\u2010methylenedioxymethamphetamine (Ecstasy) in humans","volume":"45","author":"Fallon J.K.","year":"1999","journal-title":"Clin. Chem."},{"key":"e_1_2_4_26_2","doi-asserted-by":"publisher","DOI":"10.1113\/expphysiol.1998.sp004124"},{"key":"e_1_2_4_27_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1170397"},{"key":"e_1_2_4_28_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-123-4-1962"},{"key":"e_1_2_4_29_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.132.3.1329"},{"key":"e_1_2_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)78744-4"},{"key":"e_1_2_4_31_2","doi-asserted-by":"publisher","DOI":"10.1211\/0022357011777855"},{"key":"e_1_2_4_32_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1969.sp008937"},{"key":"e_1_2_4_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1994.tb03330.x"},{"key":"e_1_2_4_34_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-15702"},{"key":"e_1_2_4_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.73.855.53"},{"key":"e_1_2_4_36_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.73.861.443"},{"key":"e_1_2_4_37_2","first-page":"178","article-title":"Hyponatraemia, seizures and stupor associated with ecstasy ingestion in a female","volume":"91","author":"Magee C.","year":"1998","journal-title":"Ir. Med. J."},{"key":"e_1_2_4_38_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1480457"},{"key":"e_1_2_4_39_2","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1152\/physrev.1983.63.4.1243","article-title":"Central nervous system mediators of vasopressin release","volume":"63","author":"Sklar A.H.","year":"1983","journal-title":"Physiol. Rev."},{"key":"e_1_2_4_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(85)90347-4"},{"key":"e_1_2_4_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1995.tb01722.x"},{"key":"e_1_2_4_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(97)00527-3"},{"key":"e_1_2_4_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)04329-3"},{"key":"e_1_2_4_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(88)90564-X"},{"key":"e_1_2_4_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(90)90012-G"},{"key":"e_1_2_4_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0301-0082(96)00027-5"},{"key":"e_1_2_4_47_2","doi-asserted-by":"publisher","DOI":"10.1021\/tx00006a008"},{"key":"e_1_2_4_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000645"},{"key":"e_1_2_4_49_2","doi-asserted-by":"publisher","DOI":"10.2190\/WMY8-EXKD-N442-ERDQ"},{"key":"e_1_2_4_50_2","unstructured":"Jackson E.K. 1996. Vasopressin and other agents affecting the renal conservation of water.InGoodman & Gilman's The Pharmacological Basis of Therapeutics. J.G. Hardmanet al. eds.: 715\u2010731. McGraw\u2010Hill. London UK."},{"key":"e_1_2_4_51_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704502"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2002.tb04181.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2002.tb04181.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T04:50:23Z","timestamp":1695617423000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2002.tb04181.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["10.1111\/j.1749-6632.2002.tb04181.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2002.tb04181.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6]]}}}